WS01: Mucosal-Skin Immunity 1
WS01-04-O/P
Unraveling the transcriptional Regulation of CD4+ TRM in Crohn’s Disease
Mitsuru Arase (Osaka University)
WS02: Cytotoxic T cells
WS02-12-O/P
Vitamin C treatment enhances the immune responses of CD8+ T cells by upregulation of Batf3
Kenta Kondo (Shiga University)
WS03: In vivo model and new cancer immunotherapy
WS03-11-O/P
Complete humanization of MHC region in mouse
Teruhiko Suzuki (Tokyo Metropolitan Institute of Medical Science )
WS04: Innate Immunity 1: Innate inflammation and disease
WS04-07-O/P
The role of small neutral amino acid transport in macrophage metabolic reprogramming during
inflammation
Shota Yasukura (Kyoto University)
WS05: Allergy
WS05-11-O/P
TRPV1-positive vagal sensory neurons suppress eosinophilic lung inflammation through the neuronintrinsic
JAK1-CGRP beta axis
Masato Tamari (National Research Institute for Child Health and Development)
WS06: Arthritis and Fibrosis
WS06-01-O/P
Distinct proliferative and spatial properties of peripheral helper T cells in rheumatoid arthritis synovium
Yuki Masuo (Kyoto University)
WS07: Macrophage 1
WS07-08-O/P
TAK1-binding protein 2 (TAB2) suppresses aberrant activation of NLRP3 inflammasome mediated by
autocrine TNF-α
Giichi Takaesu (University of the Ryukyus)
WS08: Infection immunity 1
WS08-07-O/P
History of infection and vaccination affects the quality of T cell responses in humans
Dongyun Lu (Kyoto University)
WS09: Mucosal-Skin Immunity ２
WS09-02-O/P
Novel Metabolites Altered by Appendectomy Lead to Tuft Cell Hyperplasia and Play an Important Role in
the Amelioration of Ulcerative Colitis
Shunya Hatai (RIKEN/Osaka University)
WS10: Tissue inflammation controlled by T cells
WS10-07-O/P
The T cell receptor specificity contributes to Th1-type effector regulatory T cell differentiation
Shun Yuasa (The University of Tokyo)
WS11: Tumor microenvironment and biomarkers
WS11-14-O/P
Genetically encoded fluorescent lactate biosensors for investigating tumor-immune microenvironment
Yusuke Nasu (The University of Tokyo/Japan Science and Technology Agency)
WS12: Innate Immunity 2: Innate immune cell
WS12-09-O/P
ILC1-Derived Amphiregulin Regulates Epithelial Turnover in Response to Mechanical Stress in the Skin
Tetsuro Kobayashi (RIKEN)
WS13: Hematopoiesis and immune environment
WS13-08-O/P
A novel synergistic activity of bHLH transcription factor E2A and Erg instructs B cell lineage commitment
by regulating the enhancer landscape
Reiko Hidaka (Kyoto University)
WS14: Macrophage 2
WS14-04-O/P
Periportal macrophages protect against commensal-driven liver inflammation
Yu Miyamoto (Osaka University)
WS15: Infection immunity 2
WS15-15-O/P
Sex bias in the immune response to the emerging fungal pathogen Sporothrix brasiliensis
Fabio Seiti Yamada Yoshikawa (Chiba University)
WS16: TCR-mediated signaling
WS16-18-P
γδ T cell-mediated activation of cDC1 orchestrates CD4+ Th1 cell priming in malaria
Yarob Ibraheem (Nagasaki University)
WS17: B cell activation and differentiation
WS17-07-O/P
Humanized BCR mice are a useful tool for analysis of autoreactive B cells
Rinka Ito (Kyushu University)
WS18: Infection immunity 3
WS18-16-O/P
Pilus-based vaccine development to prevent Group A Streptococcal infections
Jacelyn Mei San Loh (The University of Auckland/Maurice Wilkins Centre)
WS19: Tolerance and immune suppression focusing on regulatory T cell biology
WS19-02-O/P
Foxp3 corporates with NFκB to promote endogenous Foxp3 transcription in vivo
Yuxi Wei (The University of Tokyo)
WS20: Organ-Specific Immune Diseases
WS20-04-O/P
Ketogenic diet regulates autoimmune neuroinflammation via changes in small intestinal gut microbiome
Katsuki Yaguchi (RIKEN/Yokohama City University)
WS21: Granulocytes and Mast cells in homeostasis and diseases
WS21-07-O/P
Deficiency of the antioxidant stress response master transcription factor Nrf2 ameliorates IgE-induced
anaphylaxis in mice by suppressing IgE-dependent activation of mast cells
Sakura Noguchi (Tokyo University of Science)
WS22: New molecular and cellular mechanisms in cancer immunology
WS22-24-O/P
Deletion of the endoribonuclease Regnase-1 unleashes NK cell anti-tumor activity via OCT2-dependent
transcription of Ifng
Yasuharu Nagahama (Osaka University/Otsuka Pharmaceutical Co., Ltd.)
WS23: T cell regulation in host defense and disease
WS23-17-P
Interleukin 9 Mediates T Follicular Helper Cell Activation for Promoting Antibody Responses
Ippei Ikegami (Sapporo Medical University)
WS24: Dendritic cells: Molecular basis for regulation of their differentiation, activation, and function
WS24-15-O/P
Identification of CIITA degron and ubiquitination site by FBXO11
Yusuke Kasuga (Hokkaido University)
WS25: B cell homeostasis
WS25-08-O/P
The COMMD3/8 complex drives plasmablast differentiation of age-associated B cells during
extrafollicular responses in lupus
Taiichiro Shirai (Osaka University)
WS26: Systemic Immune Diseases
WS26-04-O/P
New quantitative and qualitative analytical framework of scRNAseq data reveals the pathophysiology of systemic lupus erythematosus
Masahiro Nakano (RIKEN)
WS27: Tolerance and immune suppression for disease control.
WS27-05-O/P
iPSCs engrafted in allogeneic hosts without immunosuppression induce donor-specific tolerance to secondary allografts
Tomoki Kamatani (Hokkaido University)
WS28: Cytokines and chemokines
WS28-09-O/P
Soluble ST2 aggravates asthma by enhancing IL-33-mediated eosinophilic inflammation and cytokine production in ILC2s
Pei-Chi Lo (Osaka University)
WS29: Cell therapy, vaccine, and new therapeutic modality
WS29-04-O/P
Efficient production of CAR-NK cells with a potent antitumor effect using leukocyte progenitor cells
Jia Han (Tokyo University of Science)
